Article
Online tool shows co-payments for cyclosporine
Allergan has launched a new digital tool designed to help eye-care professionals determine patient co-payments when prescribing cyclosporine ophthalmic emulsion 0.05% (Restasis) to manage dry eye.
Irvine, CA-Allergan has launched a new digital tool designed to help eye-care professionals determine patient co-payments when prescribing cyclosporine ophthalmic emulsion 0.05% (Restasis) to manage dry eye.
Using a computer or smartphone, ophthalmologists and other eye-care professionals can enter a patient’s ZIP code and then obtain the average co-pay for the health plans that have the biggest enrollments in the geographic area.
The tool is available at www.restasiscopay.com.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
